CGON Earnings

Quarterly EPS
$-0.30
Q3 2024
$-0.46
Q4 2024
$-0.45
Q1 2025
$-0.54
Q2 2025
$-0.57
Q3 2025
$-0.52
Q4 2025
$-0.71
Q1 2026
$-0.90
Q2 2026
Latest Revenue1.2M
Latest Net Income-79056000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.901.2M-79056000-66.7%
Q1 2026-$0.711.1M-60202000+1,982.7%-57.8%
Q4 2025-$0.522.3M-41309000+409.2%-13.0%
Q3 2025-$0.571.7M-43808000+3,774.4%-90.0%
Q2 2025-$0.540-41426000-100.0%-92.9%
Q1 2025-$0.4552.0K-34452000-90.2%-25.0%
Q4 2024-$0.46456.0K-31798000
Q3 2024-$0.3043.0K-20405000
Q2 2024-$0.28111.0K-18902000
Q1 2024-$0.36529.0K-16934000
CG Oncology (CGON) — Earnings